Search Results 1141-1150 of 17702 for corticosteroid

1. Rare Disease of Blood Vessels Often Undiagnosed in Early Stages - Mayo Clinic News Network

   Other immunosuppressive drugs may also be used to limit the amount of corticosteroids given, because corticosteroids can cause bothersome side effects. If ...

2. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

   Receiving corticosteroids > 20 mg of prednisone per day (or equivalent); NOTE: patients may be receiving stable (not increased within the last month) ...

3. Calcitonin (injection route) - Mayo Clinic

   Calcitonin injection is used to treat Paget's disease of the bone. It may also be used to prevent bone loss in women with postmenopausal osteoporosis and to ...

4. Nabumetone (oral route) - Mayo Clinic

   Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis (osteoarthritis and ...

5. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Systematic treatment with, or any condition requiring, either corticosteroids (>10 mg daily prednisone equivalent) or other immunosuppressive medications ...

6. Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium (PROMIS-2) - Mayo Clinic

   Treatment with long term (≥ 30 days) prednisone at a dose of greater than 15 mg a day (or equivalent dose of any other corticosteroid) (e.g., azithromycin ...

7. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

   Prior cytotoxic chemotherapy or corticosteroids for the treatment of multiple myeloma; NOTE: prior corticosteroid use for the treatment of non-malignant ...

8. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

   ... corticosteroids for a contrast allergy) are eligible for the study. The use of corticosteroids (≤ 10 mg oral prednisone or equivalent), physiologic ...

9. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   ... corticosteroids and mineralocorticoids (e.g., fludrocortisone) for ... corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) ...

10. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    ... corticosteroid) maximum exposure prior to randomization. Previous or current diagnosis of symptomatic multiple myeloma, including the presence of lytic bone ...